Case Report: Tuberculosis-Induced Autoimmune Hemolytic Anemia

Am J Trop Med Hyg. 2022 Dec 19;108(2):313-316. doi: 10.4269/ajtmh.22-0217. Print 2023 Feb 1.

Abstract

Tuberculosis (TB) is an infectious disease that affects different organs, causing multiple complications, including hematological sequelae. One of the most common TB-hematological complications is anemia of chronic disease. Very rarely autoimmune hemolytic anemia (AIHA) has been reported as an uncommon manifestation of TB. In this case, we present a female who presented with refractory AIHA, which was attributed to disseminated TB. The patient responded well to steroids, anti-TB medications, and rituximab.

Publication types

  • Case Reports

MeSH terms

  • Anemia, Hemolytic, Autoimmune* / complications
  • Anemia, Hemolytic, Autoimmune* / diagnosis
  • Anemia, Hemolytic, Autoimmune* / drug therapy
  • Antibodies, Monoclonal, Murine-Derived / therapeutic use
  • Female
  • Humans
  • Rituximab / therapeutic use
  • Steroids / therapeutic use
  • Tuberculosis, Miliary* / drug therapy

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Rituximab
  • Steroids